Zhongzhen Yi

2.8k total citations
17 papers, 1.2k citations indexed

About

Zhongzhen Yi is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Zhongzhen Yi has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Immunology and 6 papers in Biomedical Engineering. Recurrent topics in Zhongzhen Yi's work include CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (6 papers) and Nanowire Synthesis and Applications (5 papers). Zhongzhen Yi is often cited by papers focused on CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (6 papers) and Nanowire Synthesis and Applications (5 papers). Zhongzhen Yi collaborates with scholars based in United States, Netherlands and Germany. Zhongzhen Yi's co-authors include Stephen Gottschalk, Hao Liu, Giedre Krenciute, Meng-Fen Wu, Brooke Prinzing, Gianpietro Dotti, Kevin Chow, Irina V. Balyasnikova, Donald R. Shaffer and Sunitha Kakarla and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Zhongzhen Yi

15 papers receiving 1.2k citations

Peers

Zhongzhen Yi
Kevin Chow United States
Vita S. Brawley United States
Tessa Gargett Australia
Meenakshi Hegde United States
Carter M. Suryadevara United States
Amanda A. Bouffard United States
Donald R. Shaffer United States
Araceli Naranjo United States
Chuang Sun United States
Yvonne Kew United States
Kevin Chow United States
Zhongzhen Yi
Citations per year, relative to Zhongzhen Yi Zhongzhen Yi (= 1×) peers Kevin Chow

Countries citing papers authored by Zhongzhen Yi

Since Specialization
Citations

This map shows the geographic impact of Zhongzhen Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongzhen Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongzhen Yi more than expected).

Fields of papers citing papers by Zhongzhen Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongzhen Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongzhen Yi. The network helps show where Zhongzhen Yi may publish in the future.

Co-authorship network of co-authors of Zhongzhen Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongzhen Yi. A scholar is included among the top collaborators of Zhongzhen Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongzhen Yi. Zhongzhen Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Ibañez-Vega, Jorge, Nikhil Hebbar, Zhongzhen Yi, et al.. (2024). Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cells. STAR Protocols. 5(4). 103422–103422.
4.
Haydar, Dalia, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.. (2023). CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity. Cancer Research Communications. 3(12). 2430–2446. 10 indexed citations
5.
Ibañez-Vega, Jorge, Nikhil Hebbar, Zhongzhen Yi, et al.. (2023). GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. Cell Reports Medicine. 4(11). 101297–101297. 12 indexed citations
6.
Zebley, Caitlin C., Christopher T. Petersen, Brooke Prinzing, et al.. (2020). De novo DNA methylation programs regulate CAR T-cell exhaustion. The Journal of Immunology. 204(1_Supplement). 246.5–246.5. 5 indexed citations
7.
Haydar, Dalia, Haley Houke, Jason Chiang, et al.. (2020). Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Neuro-Oncology. 23(6). 999–1011. 89 indexed citations
8.
Yi, Zhongzhen, et al.. (2018). Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma. Molecular Therapy — Methods & Clinical Development. 9. 70–80. 94 indexed citations
9.
Kruse, Robert L., Thomas Shum, Haruko Tashiro, et al.. (2018). HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice. Cytotherapy. 20(5). 697–705. 65 indexed citations
10.
Krenciute, Giedre, Brooke Prinzing, Zhongzhen Yi, et al.. (2017). Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants. Cancer Immunology Research. 5(7). 571–581. 255 indexed citations
11.
Shum, Thomas, Bilal Omer, Haruko Tashiro, et al.. (2017). Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells. Cancer Discovery. 7(11). 1238–1247. 220 indexed citations
12.
Hegde, Meenakshi, Christopher DeRenzo, Huimin Zhang, et al.. (2017). Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.. Journal of Clinical Oncology. 35(15_suppl). 10508–10508. 34 indexed citations
13.
Prinzing, Brooke, Zhongzhen Yi, Irina V. Balyasnikova, et al.. (2017). IMMU-17. TRANSGENIC EXPRESSION OF IL15 IMPROVES ANTIGLIOMA ACTIVITY OF IL13RΑ2-CAR T CELLS. Neuro-Oncology. 19(suppl_4). iv31–iv31. 1 indexed citations
14.
Krebs, Simone, Kevin Chow, Zhongzhen Yi, et al.. (2014). T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1. Cytotherapy. 16(8). 1121–1131. 63 indexed citations
15.
Chow, Kevin, Swati Naik, Sunitha Kakarla, et al.. (2012). T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma. Molecular Therapy. 21(3). 629–637. 196 indexed citations
16.
Shaffer, Donald R., Andrea M. Sheehan, Zhongzhen Yi, et al.. (2011). Aggressive peripheral CD70‐positive t‐cell lymphoma associated with severe chronic active EBV infection. Pediatric Blood & Cancer. 59(4). 758–761. 5 indexed citations
17.
Shaffer, Donald R., Barbara Savoldo, Zhongzhen Yi, et al.. (2011). T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies. Blood. 117(16). 4304–4314. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin Chow Breakdown of academic impact, for papers by Vita S. Brawley Breakdown of academic impact, for papers by Tessa Gargett Breakdown of academic impact, for papers by Meenakshi Hegde Breakdown of academic impact, for papers by Carter M. Suryadevara Breakdown of academic impact, for papers by Amanda A. Bouffard Breakdown of academic impact, for papers by Donald R. Shaffer Breakdown of academic impact, for papers by Araceli Naranjo Breakdown of academic impact, for papers by Chuang Sun Breakdown of academic impact, for papers by Yvonne Kew
Rankless by CCL
2026